Anesthesiology, Pain Medicine · Durham, NC
NPI
1285679845
Since 2006
Specialty
Anesthesiology, Pain Medicine
Code 207LP2900X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2609 N Duke St, Suite 303b
Durham, NC, 27704
Phone (919) 220-0107
Groups this clinician bills Medicare through
Medicare paid, 2024
$288K
2,828 services
Medicare patients, 2024
112
Average age 61
Drug cost, 2024
$959K
10,125 prescriptions
Company payments, 2025
$246
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kwadwo Gyarteng-Dakwa was code 99214 (office e&m - established), 777 times for 104 patients. In total Kwadwo Gyarteng-Dakwa billed 2,828 services in 23 codes, and Medicare paid $288K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-08-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 777 | 104 | $91.38 | $71K |
| 80307 Drug Tests | Office | 755 | 105 | $60.55 | $46K |
| G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 368 | 98 | $240.80 | $89K |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 308 | 85 | $193.03 | $59K |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 77 | 43 | $153.46 | $12K |
| 99349 Home E&M - New and Established | Office | 59 | 21 | $98.00 | $5,782 |
| 99204 Office E&M - New | Office | 14 | 14 | $114.77 | $1,607 |
By year: 2022 $465K for 4,370 services; 2023 $402K for 3,204 services; 2024 $288K for 2,828 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 755 | 105 | $60.55 | $46K |
| G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 368 | 98 | $240.80 | $89K |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 308 | 85 | $193.03 | $59K |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 77 | 43 | $153.46 | $12K |
Medicare prescription drug claims, 2024
In 2024, the drug Kwadwo Gyarteng-Dakwa prescribed most often to Medicare patients was Oxycodone Hcl, with 2,465 prescriptions and refills. In total Kwadwo Gyarteng-Dakwa wrote 10,125 Medicare prescriptions that cost $959K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone Hcl Generic | 2,465 | 2,465 | 284 | $54K |
| Cyclobenzaprine Hcl Generic | 1,173 | 1,173 | 237 | $76K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 1,077 | 1,079 | 138 | $42K |
| Diclofenac Potassium Generic | 517 | 517 | 165 | $27K |
| Tizanidine Hcl Generic | 478 | 486 | 72 | $6,590 |
| Gabapentin Generic | 439 | 448 | 63 | $5,615 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 428 | 428 | 63 | $14K |
| Diclofenac Sodium Generic | 384 | 389 | 86 | $16K |
| Pregabalin Generic | 337 | 341 | 57 | $6,026 |
| Ibuprofen Generic | 313 | 314 | 50 | $3,211 |
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 190 | 194 | 27 | $35K |
| Meloxicam Generic | 185 | 185 | 36 | $516 |
| Hydroxyzine Hcl Generic | 145 | 151 | 23 | $932 |
| Duloxetine Hcl Generic | 137 | 142 | 18 | $1,436 |
| Baclofen Generic | 134 | 138 | 21 | $1,270 |
Brand drugs: 450 claims; generic drugs: 9,645 claims; opioid claims: 4,425.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kwadwo Gyarteng-Dakwa $246 ($246 in general payments such as food, travel and fees) from 7 companies. The largest payer was Curonix LLC with $59.26.
| Company | Payments | Amount |
|---|---|---|
| Curonix LLC | 2 | $59.26 |
| SPR Therapeutics, Inc | 1 | $55.73 |
| TerSera Therapeutics LLC | 1 | $37.47 |
| Globus Medical, Inc. GMED | 2 | $32.44 |
| Fidia Pharma USA Inc. | 1 | $22.18 |
| Nalu Medical, Inc. | 1 | $19.61 |
| Protega Pharmaceutials Inc | 1 | $19.5 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.